Feras Alfraih
About
Feras Alfraih is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health.
According to data from OpenAlex, Feras Alfraih has authored 25 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Public Health, Environmental and Occupational Health and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Feras Alfraih's work include Acute Lymphoblastic Leukemia research (10 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Feras Alfraih is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Childhood Cancer Survivors' Quality of Life (7 papers). Feras Alfraih collaborates with scholars based in Saudi Arabia, Egypt and United States. Feras Alfraih's co-authors include Riad El Fakih, Mahmoud Aljurf, Amr Hanbali, Shahrukh K. Hashmi, Syed Osman Ahmed, Yeow Tee Goh, Adetola A. Kassim, Marwan Shaheen, Aaron L. Sverdlov and Courtney D. Fitzhugh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Human Genetics.
In The Last Decade
Feras Alfraih
20 papers receiving 139 citations
Peers
Feras Alfraih
Olga Mulas Italy
Anne‐Lise Ménard France
Christos Demosthenous Greece
Nydia Strachman Bacal Brazil
George Chan New Zealand
Habib El‐Khoury United States
Naoki Shingai Japan
Diego V. Clé Brazil
Anne S. Renteria United States
Sara Varea Spain
Citations per year, relative to Feras Alfraih Feras Alfraih (= 1×)
peers
Olga Mulas
Countries citing papers authored by Feras Alfraih
Since
Specialization
Citations
This map shows the geographic impact of Feras Alfraih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feras Alfraih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feras Alfraih more than expected).
Fields of papers citing papers by Feras Alfraih
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Feras Alfraih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feras Alfraih. The network helps show where Feras Alfraih may publish in the future.
Co-authorship network of co-authors of Feras Alfraih
This figure shows the co-authorship network connecting the top 25 collaborators of Feras Alfraih. A scholar is included among the top collaborators of Feras Alfraih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feras Alfraih. Feras Alfraih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Alfraih, Feras, Ahmad Alhuraiji, Murtadha Al‐Khabori, et al.. (2023). Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group . Cancer Reports. 7(2). e1931–e1931.
2.
AlSheef, Mohammed, et al.. (2023). The Saudi Consensus for the Management of Cancer-Associated Thromboembolism: A Modified Delphi-Based Study. SHILAP Revista de lepidopterología. 7(1). e14–e29.
3.
Abouelhoda, Mohamed, et al.. (2023). Mining local exome and HLA data to characterize pharmacogenetic variants in Saudi Arabia. Human Genetics. 143(2). 125–136.
4.
Alshehri, Mohammed, Tusneem Elhassan, Riad El Fakih, et al.. (2023). Comparable Outcomes of Relapsed Acute Lymphoblastic Leukemia in Adolescents and Young Adults (AYA) Patients Treated with Pediatric-Inspired Chemotherapy (R3 protocol) Versus Adult-Based Salvage (FA) Protocol. Blood. 142(Supplement 1). 5903–5903.
5.
Alzahrani, Hazzaa, Ali Alahmari, Syed Osman Ahmed, et al.. (2023). Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source. Cytotherapy. 25(12). 1331–1337.
6.
Awan, Farrukh T., Daniel Addison, Feras Alfraih, et al.. (2022). International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL. Blood Advances. 6(18). 5516–5525.
7.
Hanbali, Amr, Riad El Fakih, Feras Alfraih, et al.. (2021). Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center. SHILAP Revista de lepidopterología. 16. 100270–100270.
8.
Fakih, Riad El, Walid Rasheed, Syed Osman Ahmed, et al.. (2021). The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities. SHILAP Revista de lepidopterología. 2(2). 249–256.
9.
Bakshi, Nasir, Walid Rasheed, Feras Alfraih, et al.. (2020). Evaluation of Eltrombopag in Thrombocytopenia Post Hematopoietic Cell Transplantation. Hematology/Oncology and Stem Cell Therapy. 15(1). 7–13.
10.
Alfraih, Feras, Mahmoud Aljurf, Hind Alhumaidan, et al.. (2020). High-resolution HLA allele and haplotype frequencies of the Saudi Arabian population based on 45,457 individuals and corresponding stem cell donor matching probabilities. Human Immunology. 82(2). 97–102.
11.
Bazarbashi, Shouki, et al.. (2020). Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP). Saudi Pharmaceutical Journal. 29(2). 115–120.
12.
Alhuraiji, Ahmad, Feras Alfraih, Ramesh Pandita, et al.. (2020). Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic.. PubMed. 1(33). 7–18.
13.
Hanbali, Amr, Riad El Fakih, Feras Alfraih, et al.. (2019). Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome. Clinical Lymphoma Myeloma & Leukemia. 19(10). 670–677.
14.
Fakih, Riad El, Naeem Chaudhri, Feras Alfraih, et al.. (2019). Complexity of chronic-phase CML management after failing a second-generation TKI. Leukemia & lymphoma. 61(4). 776–787.
15.
Gaafar, Ameera, Fahad Almohareb, Abdelmoneim Eldali, et al.. (2018). Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community. Bone Marrow Transplantation. 53(9). 1170–1179.
16.
Fakih, Riad El, Amr Hanbali, Yousef M. Hawsawi, et al.. (2018). Philadelphia-like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives. Experimental Hematology. 67. 1–9.
17.
Chaudhri, Naeem, et al.. (2017). Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries. Hematology/Oncology and Stem Cell Therapy. 10(4). 203–210.
18.
Fakih, Riad El, Syed Osman Ahmed, Feras Alfraih, & Amr Hanbali. (2017). Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients. Hematology/Oncology and Stem Cell Therapy. 10(4). 252–258.
19.
Hanbali, Amr, Marwan Shaheen, Feras Alfraih, et al.. (2017). A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil. Hematology/Oncology and Stem Cell Therapy. 11(4). 241–244.
20.
Alfraih, Feras, Mahmoud Aljurf, Courtney D. Fitzhugh, & Adetola A. Kassim. (2016). Alternative donor allogeneic hematopoietic cell transplantation for hemoglobinopathies. Seminars in Hematology. 53(2). 120–128.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Olga Mulas Breakdown of academic impact, for papers by Anne‐Lise Ménard Breakdown of academic impact, for papers by Christos Demosthenous Breakdown of academic impact, for papers by Nydia Strachman Bacal Breakdown of academic impact, for papers by George Chan Breakdown of academic impact, for papers by Habib El‐Khoury Breakdown of academic impact, for papers by Naoki Shingai Breakdown of academic impact, for papers by Diego V. Clé Breakdown of academic impact, for papers by Anne S. Renteria Breakdown of academic impact, for papers by Sara Varea